MLL Legal advised Lipomed AG on all legal and tax aspects of this complex cross-border transaction where assets and a foreign subsidiary of Lipomed AG were sold to LGC.
The team was led by Daniel Schoch (partner corporate | M&A) and included Simon Holzer (partner life science), Thomas Nabholz (partner tax), Lukas Bühlmann (partner ICT), David Peter (senior associate), Xenia Pisarewski (associate) and Fabio Lavarini (junior associate).
Lipomed Reference Standards is a leading manufacturer and supplier of analytical reference standards with ISO/IEC 17025 accreditations for testing and ISO 17034 accreditation for production of reference materials. The products are marketed and distributed in more than 50 countries around the world.
Lipomed is a privately owned and internationally operating Swiss life science company with pharmaceutical production facilities located near Basel. It is dedicated to the research, development, manufacturing, and commercialization of API and ethical pharmaceuticals with a particular focus on hematology, oncology, and other niche indications
LGC is a leading global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments.